The Lain American Lawyer: March 2018 Latam_March 2018 | Page 16

Report Pacific Alliance
believes fulfilling common technical and legal requirements from the health authorities requires dynamism . “ This involves designing regional investment strategies in the research and development of competitive and novel products , in order to meet the highest standards ,” she says . Meanwhile , Helena Camargo , partner at Posse Herrera Ruiz in Bogota , notes there are no common rules for patent protection or regulatory matters through the trading bloc . “ Therefore , the big challenge these companies face is the multiplicity of different rules , requisites and practices across the region .” She adds that the necessary technical information has to be planned for each country , as there is not uniformity in what each of the relevant authorities will request . “ A company that arrives in the Pacific Alliance needs to have a country-by-country

approach ,” Camargo says . Restrictive
Ricardo De Vettor , senior associate at Rodrigo , Elías & Medrano in Lima , Peru , also argues that there are no regional trends or strategies regarding these products [ with the exception of cosmetic products ]. “ The permits required to import , distribute and commercialise the rest of the mentioned products vary , depending on the local legislation of each country ,”
2017 Top Pharmaceutical Deals in Latin America
Buyer
Country of Buyer
Target
Country of
Target
Value ( USD million )
Brigadier Gold
Canada
Keraderm
Colombia
4.0000248315
ICU Medical Latam
United States
Hospira Peru
Peru
4.7300255764
Florence Capital
Advisors
United States
Establishment Labs
Costa Rica
18.0000247258
Kilowatt Capital
United States
Establishment Labs
Costa Rica
18.0000247258
Laboratorio
Roemmers
Argentina
Elisium
Argentina
20.0000252052
Carfepe
Brazil
Vallee
Brazil
21.7761244748
GBT - Grupo
Biotoscana
Uruguay
Laboratorio Dosa
Argentina
29.9000254864
Natura
Brazil
The Body Shop
United Kingdom
1201.800024937
Elea
Argentina
Laboratorios Phoenix
Argentina
Not disclosed
Farmabase
Brazil
Cevasa
Argentina
Not disclosed
Phibro Animal
Health
United States
Biotay
Argentina
Not disclosed
BSB Hospitalar
Brazil
Tecnocold
Brazil
Not disclosed
CM Hospitalar
Brazil
Tecnocold
Brazil
Not disclosed
CM Logistica
Hospitalar
Brazil
Tecnocold
Brazil
Not disclosed
Roquette Brasil
Brazil
Itacel
Brazil
Not disclosed
Stigma II
United States
Brasil Pharma
Brazil
Not disclosed
Operadora de
Centro Mezclas
Mexico
Asisfarma
Colombia
Not disclosed
Merieux NutriSciences Corporation
United States
Tecnimicro Laboratorio de Analisis
Colombia Not disclosed
Henkel
Germany
Nattura Laboratorios
Mexico
Not disclosed
Grupo Pochteca
Mexico
Conjunto LAR de Mexico
Mexico
Not disclosed
Faes Farma
Spain
MIT Farma
Mexico
Not disclosed
Synlab International
Germany
Medlab Cantella-Colichon
Peru
Not disclosed
Unilabs
Switzerland
Blufstein Laboratorio
Clinico
Peru
Not disclosed
Intervet Holding
Netherlands
Prondil
Uruguay
Not disclosed
Supplied by TTR - Transactional Track Recor he says , before highlighting another issue in Peru . “ Our local laws prohibit foreign companies from owning sanitary authorisations ,”
health regulation is a big challenge for life sciences companies .

Ariela Agosin Albagli Zaliasnik ”

he says . “ The problem with this situation is that overseas companies must enter into business alliances with local players and be subject to their goodwill .”
Elsewhere , Maritza Reátegui , partner at Peruvian law firm Muñiz , Olaya , Meléndez , Castro , Ono & Herrera Abogados , highlights that the biggest challenge for life science companies is the integration of the regulations in the individual countries of the Pacific Alliance , which requires that all stakeholders are convinced of their viability and implementation . “ A change of culture is required to take advantage of the opportunities for the exchange of products and services ,” she adds .
However , such is the need for life science companies to have the best possible legal certainty and safety , that lawyers in the Pacific Alliance countries find growing opportunities advising clients in the sector . “ Lawyers must be the strategic advisor of the company ,” says Pieschacon . Campos Vargas agrees . “ The greatest opportunity is to provide clients and players in these industries with a comprehensive analysis of the local market and the related legal system ,” he explains . “ Lawyers must be knowledgeable not only in their specific field of expertise or practice , but must also understand the industry as a whole , as well as able to provide a comprehensive view of the challenges .”
Lawyers must have a clear , complete and extensive experience in the technical side in addition
14 • THE LATIN AMERICAN LAWYER • March 2018 www . thelatinamericanlawyer . com